Stock Financial Ratios


IVOB / INVO BioScience, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.37
Volume0.00
Market Cap ($M)52.27
Enterprise Value ($M)52.26
Book Value ($M)-4.62
Book Value / Share-0.03
Price / Book-10.88
NCAV ($M)-4.49
NCAV / Share-0.03
Price / NCAV-11.02
Income Statement (mra) ($M)
Revenue0.05
EBITDA-2.11
Net Income-2.12
Balance Sheet (mrq) ($M)
Cash & Equivalents0.04
Cash / Share0.00
Assets0.20
Liabilities5.08
Quick Ratio0.03
Current Ratio0.05
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.46
Return on Assets (ROA)-7.42
Return on Equity (ROE)0.46
Identifiers and Descriptors
CUSIP44984F104
Central Index Key (CIK)1417926
Industry Groups
Share Statistics
Common Shares Outstanding (M)141.68
Scoring Models
Piotroski F Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Cash And Equivalents Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Assets Current Per Share0.00
Minority Interest Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Current Per Share0.04
Long Term Debt Per Share0.00
Assets Other Current Per Share0.00
Cash Per Share0.00
Accounts Payable Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Retained Earnings Per Share-0.13
Inventory Per Share0.00
Liabilities And Stock Equity Per Share0.00
Equity Per Share-0.04
Assets Other Non Current Per Share0.00
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.00
Treasury Stock Per Share0.00
Debt Per Share0.00
Assets Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Additional Paid In Capital Per Share0.10
Liabilities Per Share0.04

Related News Stories

INVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of Directors

2017-10-11 accesswire
MEDFORD, MA / ACCESSWIRE / October 11, 2017 / INVO Bioscience, Inc. (OTC PINK: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced the addition of Michael J. Campbell and Steven Shum to its board of directors. Mr. Campbell and Mr. Shum bring the total number of board members to five, with three classified as independent directors under FINRA rules. (53-0)

CUSIP: 44984F104